Ankyra Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Ankyra Therapeutics's estimated annual revenue is currently $1.7M per year.
- Ankyra Therapeutics's estimated revenue per employee is $77,500
- Ankyra Therapeutics's total funding is $59.5M.
Employee Data
- Ankyra Therapeutics has 22 Employees.
- Ankyra Therapeutics grew their employee count by 47% last year.
Ankyra Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | President and CEO | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | EVP Process and Manufacturing Sciences | Reveal Email/Phone |
5 | VP Research And Development | Reveal Email/Phone |
6 | VP Regulatory Affairs | Reveal Email/Phone |
7 | VP Clinical Development | Reveal Email/Phone |
8 | Sr. Director, Clinical Operations | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Ankyra Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Ankyra Therapeutics?
Developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response
keywords:N/A
$59.5M
Total Funding
22
Number of Employees
$1.7M
Revenue (est)
47%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ankyra Therapeutics News
2022-04-17 - Ankyra Therapeutics Announces Cooperative Research and ...
Ankyra Therapeutics Announces Cooperative Research and Development Agreement with the National Cancer Institute. Published: Apr 18, 2022. BOSTON--(BUSINESS...
2022-03-30 - The Petri Dish: Adagio says its antibody works against ...
Ankyra Therapeutics, a cancer startup co-founded by Dartmouth College professor and serial entrepreneur Tillman Gerngross, has promoted its...
2022-03-22 - Ankyra Therapeutics Appoints Howard L. Kaufman, MD as ...
BOSTON--(BUSINESS WIRE)--Ankyra Therapeutics, a company developing cancer therapies based on tumor localized immune potentiating agents,...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.1M | 22 | 0% | N/A |
#2 | $3.1M | 22 | -8% | N/A |
#3 | $1.7M | 22 | -33% | $173M |
#4 | $2.2M | 22 | 5% | N/A |
#5 | $1.8M | 22 | -27% | N/A |